Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States

BACKGROUND. Two vaccines protect against human papillomaviruses (HPV) 16 and 18, which cause 70% of cervical cancer and 50% of cervical intraepithelial neoplasia 2/3 and adenocarcinoma in situ (CIN2+). Monitoring HPV types in CIN2+ may be used to assess HPV vaccine impact. METHODS. As part of a mult...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Hariri, Susan, Unger, Elizabeth R., Powell, Suzanne E., Bauer, Heidi M., Bennett, Nancy M., Bloch, Karen C., Niccolai, Linda M., Schafer, Sean, Steinau, Martin, Markowitz, Lauri E.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7506816/
https://ncbi.nlm.nih.gov/pubmed/23045628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis627
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars